ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report) was up 6.2% during mid-day trading on Wednesday . The stock traded as high as $0.41 and last traded at $0.40. Approximately 570,017 shares were traded during mid-day trading, an increase of 2,704% from the average daily volume of 20,327 shares. The stock had previously closed at $0.38.
ImmunoPrecise Antibodies Price Performance
The company’s 50-day simple moving average is $0.46 and its 200-day simple moving average is $0.50.
ImmunoPrecise Antibodies Company Profile
ImmunoPrecise Antibodies Ltd. engages in the provision of human therapeutic antibody discovery and development services. It offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization.
See Also
- Five stocks we like better than ImmunoPrecise Antibodies
- Using the MarketBeat Dividend Yield Calculator
- Ramaco Resources Pins Hopes on Coal’s Untapped Potential
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Why Energy Transfer Belongs on Your Watchlist
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
